Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Fleshner

Showing results (31-40 of 292) with videos related to

Pageof 30
Sort By:
JAMA Oncology|November 30, 2018
Abiraterone Acetate for Nonmetastatic Castration-Resistant Prostate Cancer-The Forgotten Dance Partner?Zachary Klaassen, Christopher J D Wallis, Neil E Fleshner
European Urology|September 28, 2025
Reply to Nour Khalil, Guiseppe Maiolino, and Eric Barret's Letter to the Editor re: Rui M. Bernardino, Theodorus van der Kwast, Neil E. Fleshner. Intraductal Carcinoma and Cribriform Pattern in Prostate Cancer: Challenges and Emerging Perspectives. Eur Urol 2025;88:123-5Rui M Bernardino, Theodorus van der Kwast, Neil E Fleshner
International Urology and Nephrology|April 2, 2024
Editorial comment to the paper: RE: low cubilin/myeloperoxidase's ratio as a promising biomarker for prognosis of high grade T1 bladder cancerRui M Bernardino, Marian Wettstein, Juan Garisto, et al.
Nature Reviews. Urology|December 10, 2009
Nutraceuticals and prostate cancer prevention: a current reviewGreg Trottier, Peter J Boström, Nathan Lawrentschuk, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 15, 2013
Urologists in cyberspace: A review of the quality of health information from American urologists' websites using three validated toolsLih-Ming Wong, Hanmu Yan, David Margel, et al.
European Urology|January 31, 2025
Intraductal Carcinoma and Cribriform Pattern in Prostate Cancer: Challenges and Emerging PerspectivesRui M Bernardino, Theodorus van der Kwast, Neil E Fleshner
Expert Review of Anticancer Therapy|July 1, 2008
The REDUCE trial: chemoprevention in prostate cancer using a dual 5alpha-reductase inhibitor, dutasterideMireia Musquera, Neil E Fleshner, Antonio Finelli, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 16, 2010
Radical prostatectomy in obese patients: Improved surgical outcomes in recent yearsUri Lindner, Nathan Lawrentschuk, Robert Abouassaly, et al.
Lipid Insights|May 20, 2015
The effects of serum from prostate cancer patients with elevated body mass index on prostate cancer cells in vitroBenjamin C Mora, Neil E Fleshner, Laurence H Klotz, et al.
Urologic Oncology|March 12, 2010
Clinical significance of the positive surgical margin based upon location, grade, and stageNeil E Fleshner, Andrew Evans, Karen Chadwick, et al.
Pageof 30

Showing results (31-40 of 292) with videos related to

Sort By:
Pageof 30
JAMA Oncology|November 30, 2018
Abiraterone Acetate for Nonmetastatic Castration-Resistant Prostate Cancer-The Forgotten Dance Partner?Zachary Klaassen, Christopher J D Wallis, Neil E Fleshner
European Urology|September 28, 2025
Reply to Nour Khalil, Guiseppe Maiolino, and Eric Barret's Letter to the Editor re: Rui M. Bernardino, Theodorus van der Kwast, Neil E. Fleshner. Intraductal Carcinoma and Cribriform Pattern in Prostate Cancer: Challenges and Emerging Perspectives. Eur Urol 2025;88:123-5Rui M Bernardino, Theodorus van der Kwast, Neil E Fleshner
International Urology and Nephrology|April 2, 2024
Editorial comment to the paper: RE: low cubilin/myeloperoxidase's ratio as a promising biomarker for prognosis of high grade T1 bladder cancerRui M Bernardino, Marian Wettstein, Juan Garisto, et al.
Nature Reviews. Urology|December 10, 2009
Nutraceuticals and prostate cancer prevention: a current reviewGreg Trottier, Peter J Boström, Nathan Lawrentschuk, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 15, 2013
Urologists in cyberspace: A review of the quality of health information from American urologists' websites using three validated toolsLih-Ming Wong, Hanmu Yan, David Margel, et al.
European Urology|January 31, 2025
Intraductal Carcinoma and Cribriform Pattern in Prostate Cancer: Challenges and Emerging PerspectivesRui M Bernardino, Theodorus van der Kwast, Neil E Fleshner
Expert Review of Anticancer Therapy|July 1, 2008
The REDUCE trial: chemoprevention in prostate cancer using a dual 5alpha-reductase inhibitor, dutasterideMireia Musquera, Neil E Fleshner, Antonio Finelli, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 16, 2010
Radical prostatectomy in obese patients: Improved surgical outcomes in recent yearsUri Lindner, Nathan Lawrentschuk, Robert Abouassaly, et al.
Lipid Insights|May 20, 2015
The effects of serum from prostate cancer patients with elevated body mass index on prostate cancer cells in vitroBenjamin C Mora, Neil E Fleshner, Laurence H Klotz, et al.
Urologic Oncology|March 12, 2010
Clinical significance of the positive surgical margin based upon location, grade, and stageNeil E Fleshner, Andrew Evans, Karen Chadwick, et al.
Pageof 30